Titan Pharmaceuticals's total assets for Q1 2025 were $2.16M, a decrease of -26.24% from the previous quarter. TTNP total liabilities were $279.00K for the fiscal quarter, a -42.24% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.